Shifts in protein aggregate stability define proteostasis decline in the aging human brain

This study reveals that normal human brain aging involves an asymmetric remodeling of the insoluble proteome, characterized by the decline of highly stable aggregates and the progressive accumulation of intermediate-stability aggregates that are prone to phase separation and linked to Alzheimer's disease pathology, a process strongly predicted by proteasome and chaperone capacity.

The Gist

Imagine your brain as a bustling, high-tech city. For this city to run smoothly, it needs a constant supply of fresh, working machinery (proteins) and a rigorous waste management system to clear out broken or misshapen parts. This balance is called proteostasis.

As we age, we often hear that our brains get "clogged" with trash, leading to diseases like Alzheimer's. The common assumption is that this trash just piles up uniformly over time, like a landfill filling up.

However, this new study reveals a much more complex and surprising story about what happens in the aging human brain. Here is the breakdown using simple analogies:

1. The Two Types of "Trash"

The researchers didn't just look at "trash"; they sorted it into two very different categories based on how hard it is to dissolve:

• The "Concrete" Aggregates (SDS-insoluble): These are the super-hard, rock-solid clumps. Think of them like old, rusted steel beams or hardened concrete. In the past, scientists thought these just kept piling up as we got older.
• The "Gooey" Aggregates (Sarkosyl-insoluble): These are sticky, semi-solid clumps. Think of them like wet clay, slime, or a thick gel. They are less stable than concrete but still clump together.

2. The Great Swap: What Happens as We Age?

The study looked at brain tissue from women aged 20 to 88 who had no signs of dementia or Alzheimer's. They found a dramatic shift in how the brain handles these two types of trash:

• The "Concrete" Disappears: Surprisingly, the super-hard, rock-solid aggregates actually decline as we get older. By the time people reach old age, the brain has fewer of these "concrete" clumps than it did in middle age.
• The "Goo" Explodes: Meanwhile, the sticky, "gooey" aggregates start to build up slowly in middle age, but then skyrocket after age 80.

The Analogy: Imagine a construction site. In your youth, you have a few piles of solid, unmoving bricks. As you age, the crew stops making those solid bricks. Instead, they start piling up buckets of wet, sticky cement. The total amount of "waste" might look similar, but the type of waste has completely changed.

3. Why the "Goo" is Dangerous

Why does this shift matter?

• The "Concrete" was a safety net: The study suggests that the hard, rock-solid aggregates might have actually been a protective mechanism. By locking bad proteins into a solid, immovable block, the brain was safely "quarantining" them so they couldn't cause trouble.
• The "Goo" is contagious: The sticky, intermediate-stability aggregates are different. They are prone to Liquid-Liquid Phase Separation (a fancy way of saying they act like oil droplets in water that merge and grow).
  • The Metaphor: Think of the "concrete" as a sealed vault where dangerous criminals are locked away. The "goo" is like a viral video or a rumor. It spreads easily, jumps from person to person (or cell to cell), and can infect healthy parts of the city.
  • These "gooey" clumps are the exact same types of proteins found in the plaques and tangles of Alzheimer's disease.

4. The City's Cleanup Crew (Proteostasis)

The study also looked at why some people have more of this dangerous "goo" than others, even if they are the same age.

They found that the brain's cleanup crew is the deciding factor:

• The Proteasome (The Shredder): This is the machine that chops up broken proteins. People with a strong, active shredder had much less "goo" in their brains.
• Chaperones (The Guides): These are proteins that help other proteins fold correctly. Strong chaperones also kept the "goo" levels low.

The Takeaway: It's not just about getting older; it's about how well your specific cleanup crew is working. If your "shredder" and "guides" are weak, the dangerous "goo" builds up, paving the way for disease.

5. The Big Picture

This research changes the narrative on aging:

1. Aging isn't just "more trash": It's a change in the type of trash. We lose the safe, solid blocks and gain the dangerous, sticky slime.
2. The Danger Zone: The shift toward this sticky "goo" happens gradually but accelerates sharply after age 80, which is exactly when the risk for Alzheimer's spikes.
3. Hope for Intervention: Because the amount of "goo" depends heavily on the efficiency of the cleanup crew (proteasomes and chaperones), we might be able to treat or prevent neurodegenerative diseases by boosting these cleanup systems before symptoms appear.

In summary: The aging brain doesn't just get dirtier; it gets a different kind of dirt. It swaps safe, solid blocks for dangerous, sticky slime that spreads easily. Keeping our internal "cleanup crew" strong is the key to keeping that slime at bay.

Technical Summary

1. Problem Statement

Loss of proteostasis and the accumulation of insoluble protein aggregates are hallmarks of aging and neurodegenerative diseases (e.g., Alzheimer's Disease, Parkinson's Disease). While model organisms show a uniform accumulation of detergent-insoluble aggregates with age, it remains unknown how aggregation proceeds during normal human brain aging in the absence of clinical disease. Specifically, it is unclear whether aging drives a uniform increase in all aggregates or a qualitative shift in the stability states of these aggregates, and how these changes relate to the biophysical properties of proteins (e.g., amyloid formation vs. liquid-liquid phase separation).

2. Methodology

The study employed a comprehensive proteomic approach on human post-mortem brain tissue to analyze the insoluble proteome across the adult lifespan.

• Cohort: 52 disease-free female donors (aged 20–88 years) sourced from the NIH Neurobiobank. Strict exclusion criteria were applied to remove subjects with neurodegenerative, psychiatric, or major systemic diseases.
• Tissue Source: Hippocampal formation.
• Fractionation Strategy: Parallel detergent fractionation was performed on the same tissue samples to isolate proteins based on stability:
  • Sarkosyl-insoluble fraction: Enriches for aggregates with intermediate stability (often associated with liquid-liquid phase separation and seeding competence).
  • SDS-insoluble fraction: Enriches for highly stable, detergent-resistant aggregates (classical amyloids).
  • Lysate (Total): Soluble + Insoluble proteins.
• Quantification: Data-Independent Acquisition (DIA) Mass Spectrometry (MS) was used to quantify protein abundance in all fractions.
• Statistical & Computational Analysis:
  • Trajectory Modeling: Generalized Additive Models (GAMs) and clustering were used to map protein abundance changes across four age groups (Young, Middle, Old, Geriatric).
  • Biophysical Profiling: Proteins were annotated with predictors for aggregation propensity (TANGO, Zagg), solubility (CamSol), and Liquid-Liquid Phase Separation (LLPS) propensity (catGranule, FuzDrop).
  • Disease Correlation: Overlap with Alzheimer's Disease (AD) pathology (plaque/tangle proteomes from the NeuroPro database) and CSF biomarkers was assessed.
  • Predictive Modeling: Linear models were built to determine if proteostasis network capacity (e.g., proteasome, chaperones) predicts aggregate burden independently of chronological age.

3. Key Contributions & Results

A. Asymmetric Remodeling of the Insoluble Proteome

Contrary to the hypothesis of uniform accumulation, the study found a divergent, asymmetric remodeling of the insoluble proteome during aging:

• SDS-Insoluble (High Stability): 82% of proteins in this fraction declined with age. The decline was modest until midlife but accelerated sharply in the transition to old age (65–75 years).
• Sarkosyl-Insoluble (Intermediate Stability): Approximately 10% of proteins (303 proteins) accumulated progressively. This accumulation was modest until old age but accelerated significantly in the geriatric group (>80 years).
• Independence: These changes were not driven by total protein expression levels (lysate abundance remained stable) or tissue composition changes (neuronal loss was ruled out).

B. Biophysical Signatures: LLPS vs. Classical Amyloids

• SDS-Declining Proteins: Showed modest enrichment for classical aggregation features (beta-sheets, hydrophobicity) but were depleted relative to the background proteome.
• Sarkosyl-Accumulating Proteins: Exhibited a distinct biophysical signature characterized by high Liquid-Liquid Phase Separation (LLPS) propensity (high catGranule and FuzDrop scores) and RNA-binding capacity, rather than classical amyloid features.
  • These proteins were enriched for sequence length and disorder, suggesting aggregation via condensate maturation.
  • Two distinct subpopulations were identified: those driven by entropy-based disordered interactions and those driven by multivalent/RNA-binding interactions.

C. Link to Neurodegenerative Disease

• AD Enrichment: The proteins accumulating in the sarkosyl-insoluble fraction during normal aging showed significant enrichment for constituents found in Alzheimer's plaques and neurofibrillary tangles.
• Biomarkers: This accumulating pool was also enriched for established AD CSF biomarkers.
• Specific Proteins: 58 proteins increased in the sarkosyl fraction and were found in both plaques and tangles. These included synaptic scaffolding proteins, mitochondrial enzymes, RNA-binding proteins (HNRNPA2B1, HNRNPK), and proteostasis machinery (SQSTM1/p62, HSP90).

D. Proteostasis Capacity as a Determinant

• Individual Variance: Aggregate burden varied significantly among age-matched individuals.
• Predictors: The abundance of specific proteostasis machinery predicted aggregate burden as strongly as chronological age.
  • Protective Factors: Higher abundance of proteasome capacity and cytosolic chaperones was associated with lower sarkosyl-insoluble burden.
  • Risk Factors: Higher abundance of mitochondrial import machinery and biosynthetic pathways was associated with higher burden.
  • Autophagy: Interestingly, autophagy components were enriched in SDS-declining proteins but depleted in sarkosyl-accumulating proteins, suggesting autophagy clears high-stability aggregates but fails to engage intermediate-stability condensates.

4. Significance and Implications

• Redefining Aging: The study establishes that normal human brain aging is not defined by a simple accumulation of "junk" but by a qualitative shift in aggregate stability. The brain loses highly stable, sequestered deposits (SDS) while gaining labile, intermediate-stability aggregates (Sarkosyl) that are prone to seeding and propagation.
• Mechanism of Pathology: The findings suggest that LLPS-driven aggregation is a primary mechanism for the accumulation of disease-relevant proteins during normal aging. The "tipping point" for neurodegenerative disease may occur when the accumulation of these intermediate-stability aggregates overwhelms clearance mechanisms (specifically the proteasome and chaperones).
• Therapeutic Targets: The data provides human-level evidence that enhancing proteasome function and cytosolic chaperone capacity could mitigate the accumulation of disease-relevant aggregates before clinical symptoms appear.
• Sex Specificity: The study focused on females due to their higher lifetime risk of AD; future work is needed to determine if these trajectories apply to males.

In summary, this paper identifies a specific molecular trajectory in the aging human brain where the failure to clear intermediate-stability, LLPS-prone aggregates—driven by declining proteostasis capacity—creates a reservoir of proteins that overlap significantly with Alzheimer's pathology, positioning this process as a critical pre-clinical window for intervention.